Search results
Wahed Invest LLC Boosts Holdings in Pfizer Inc. (NYSE:PFE)
ETF DAILY NEWS· 2 days agoWahed Invest LLC lifted its stake in shares of Pfizer Inc. (NYSE:PFE – Free Report) by 8.6% during the 4th quarter, according to its most recent disclosure with the Securities ...
Pfizer's COVID-19 Vaccine Safety Claims Under Lens, Faces Lawsuit From Kansas For Alleged Misleading...
Benzinga· 1 day agoThe state of Kansas has reportedly filed a lawsuit against pharmaceutical giant Pfizer, Inc. PFE, accusing the company of violating consumer protection laws related to its ...
Pfizer Inc. (NYSE:PFE) Shares Sold by Trust Co. of Vermont
ETF DAILY NEWS· 2 days agoTrust Co. of Vermont lessened its holdings in shares of Pfizer Inc. (NYSE:PFE – Free Report) by 13.5% in the fourth quarter, according to the company in its most recent filing ...
Kansas attorney general sues Pfizer over COVID vaccine, company responds
KSNT Topeka via Yahoo News· 1 day agoRelated video: Class action lawsuits – what are they, and should you join one? TOPEKA (KSNT) –...
Pfizer Inc. (NYSE:PFE) Stake Boosted by Wellington Management Group LLP
ETF DAILY NEWS· 2 days agoWellington Management Group LLP lifted its stake in shares of Pfizer Inc. (NYSE:PFE – Free Report) by 4.9% during the 4th quarter, according to its most recent disclosure ...
Pfizer setback brings questions for Duchenne gene therapy ahead of Sarepta decision
BioPharma Dive via Yahoo Finance· 6 days agoThe failure of another trial adds to uncertainty around the benefits of the gene-based treatments,...
MSD competes with Pfizer in pneumococcal vaccine market after FDA approval
Pharmaceutical Technology via Yahoo Finance· 9 hours agoThis includes the eight unique serotypes, 15A, 15C, 16F, 23A, 23B, 24F, 31 and 35B compared to other...
Pfizer gene therapy for Duchenne fails to meet goals of key trial
BioPharma Dive via Yahoo Finance· 6 days agoThe negative results from the Phase 3 study, called Ciffreo, come a little more than a month after ...
Sarepta Jumps After Pfizer's Rival Gene Therapy Flops In Phase 3 Test
Investor's Business Daily· 5 days agoSarepta stock jumped Thursday after Pfizer's rival gene therapy for Duchenne muscular dystrophy...
Is It Too Late to Buy Pfizer Stock? | The Motley Fool
The Motley Fool· 5 days agoAre Pfizer's (PFE -0.43%) best days behind it? If the stock's critics are to be believed, the answer...